NEWS out:
MedCare Technologies, Inc. Announces RxSheets.com's Marketing Efforts Strengthens Leadership Position in Online Pharmaceutical Sampling
OAK BROOK, ILL., Mar 14, 2000 (BUSINESS WIRE) -- RxSheets.com, a wholly owned
subsidiary of MedCare Technologies, Inc. (NASDAQ: MCAR) announced today that the
number of physicians registered with its leading and innovative web site has
increased to over 20,000. This increase was a result of the Company's recently
launched introductory marketing campaign as well as ongoing networking efforts.
Prior to the campaign the Company had over 10,000 physicians registered to its
site.
The Company announced its plans to increase its marketing efforts on February
10, 2000 and subsequently began to introduce its business-to-business web site,
featuring online pharmaceutical sampling, to physicians across the country.
"We are extremely pleased by the tremendous response we are receiving from the
physician community," said Jeff Aronin, President and Chief Executive Officer.
"The growth in enrollment is reflecting the fact that physicians recognize the
significant value and convenience that our web site will provide to them and
their practices. With new time pressures in medicine, doctors are looking for
alternative ways to more efficiently receive valuable services that effect their
practice. The overwhelming response from physicians is validation that our
offering is a solution to these demands."
Specifically pertaining to the Company's recent marketing campaign, Aronin
concludes, "While we recognize the importance of over 20,000 doctors registering
to our site, the most significant part of our campaign, thus far, is that we
achieved this level at such an early stage. This demonstrates the compelling
nature of our offering. As a result of our online sampling service, we have been
able to get doctors to go online, which is something that many other e-health
companies have not been able to accomplish."
"The increasing enrollment will enhance our efforts to develop revenue
relationships with the pharmaceutical companies," said Gary Branning, Vice
President, Business Development. "We have been in constant contact with the
marketplace and thus far the overall reaction of pharma management has been
extremely positive. Pharma companies recognize the value of getting samples to
physicians as an effective way to influence their prescribing habits.
RxSheets.com provides the pharmaceutical industry with a new, cost effective and
focused marketing alternative."
RxSheets.com (www.rxsheets.com) is an innovative and leading
business-to-business web site catering to the pharmaceutical needs of the
practicing physician. The pharmaceutical focused site was launched in October
1999 with a strategy to revolutionize the process by which physicians obtain
pharmaceutical samples and drug related information. Many pharmaceutical
companies offer physicians samples of their drugs as part of their marketing
promotions to physicians. A trial sample of a drug is often the most effective
way to get a doctor to use a pharmaceutical company's product.
RxSheets.com offers the following information and services: Drug Samples Request
Center, FDA Approvals Library, Clinical Studies Center, News Center, Investment
Center provided by Morgan Stanley Dean Witter Online, HealthCare Calendar and
Pharmaceutical Newsletter.
MedCare Technologies, Inc. is a healthcare technology service company that
focuses on under-served high growth markets. The Company's RxSheets.com
(www.rxsheets.com), offers a wide array of compelling and focused information
and services, including drug sample requests for physicians, drug protocols and
studies, research information, and other pertinent aspects of the pharmaceutical
market. The Company began by developing the MedCare Program, now the nations
leading conservative therapy for treating urinary incontinence, a hidden health
condition that, at approximately $26 billion, costs more than diabetes and
bypass surgery combined.
This news release contains forward-looking statements as defined by the Private
Securities Litigation Reform Act of 1995. Forward-looking statements include
statements concerning plans, objectives, goals, strategies, future events or
performance and underlying assumptions and other statements which are other than
statements of historical facts. These statements are subject to uncertainties
and risks including, but not limited to, product and service demand and
acceptance, changes in technology, changes in insurance reimbursement, economic
conditions, the impact of competition and pricing, government regulation, and
other risks defined in this document and in statements filed from time to time
with the Securities and Exchange Commission. All such forward-looking
statements, whether written or oral, and whether made by or on behalf of the
Company are expressly qualified by these cautionary statements and any other
cautionary statements which may accompany the forward-looking statements. In
addition, the Company disclaims any obligation to update any forward-looking
statements to reflect events or circumstances after the date hereof. |
